Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taiwan - Delayed Quote TWD

Taiyen Biotech Co., Ltd. (1737.TW)

Compare
31.15
-0.25
(-0.80%)
At close: 1:30:15 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,238,152
3,238,152
3,408,811
3,613,607
4,095,651
Cost of Revenue
1,917,244
1,917,244
2,151,333
2,337,002
2,722,415
Gross Profit
1,320,908
1,320,908
1,257,478
1,276,605
1,373,236
Operating Expense
890,099
890,099
862,478
831,555
844,059
Operating Income
430,809
430,809
395,000
445,050
529,177
Net Non Operating Interest Income Expense
-6,338
-6,338
-3,349
-4,523
-5,942
Pretax Income
433,032
433,032
329,116
530,587
509,918
Tax Provision
115,580
115,580
111,820
103,071
97,756
Net Income Common Stockholders
371,524
371,524
300,386
426,704
393,227
Diluted NI Available to Com Stockholders
371,524
371,524
300,386
426,704
393,227
Basic EPS
1.86
--
1.50
2.13
1.97
Diluted EPS
1.85
--
1.50
2.13
1.96
Basic Average Shares
199,744.09
--
200,257.33
200,000
200,000
Diluted Average Shares
200,823.78
--
200,257.33
200,000
200,568
Total Expenses
2,807,343
2,807,343
3,013,811
3,168,557
3,566,474
Net Income from Continuing & Discontinued Operation
371,524
371,524
300,386
426,704
393,227
Normalized Income
427,436.87
427,436.87
354,243.21
426,704
393,227
Interest Expense
6,338
6,338
3,349
4,523
5,942
Net Interest Income
-6,338
-6,338
-3,349
-4,523
-5,942
EBIT
439,370
439,370
332,465
535,110
515,860
EBITDA
657,963
657,963
530,524
730,058
705,520
Reconciled Cost of Revenue
1,917,244
1,917,244
2,151,333
2,337,002
2,722,415
Reconciled Depreciation
218,593
218,593
198,059
194,948
189,660
Net Income from Continuing Operation Net Minority Interest
371,524
371,524
300,386
426,704
393,227
Total Unusual Items Excluding Goodwill
-76,270
-76,270
-81,572
--
--
Total Unusual Items
-76,270
-76,270
-81,572
--
--
Normalized EBITDA
734,233
734,233
612,096
730,058
705,520
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-20,357.13
-20,357.13
-27,714.79
--
--
12/31/2021 - 11/18/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.